GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Keryx Biopharmaceuticals Inc (NAS:KERX) » Definitions » Days Inventory

Keryx Biopharmaceuticals (Keryx Biopharmaceuticals) Days Inventory : 584.79 (As of Sep. 2018)


View and export this data going back to 2000. Start your Free Trial

What is Keryx Biopharmaceuticals Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Keryx Biopharmaceuticals's Average Total Inventories for the three months ended in Sep. 2018 was $53.66 Mil. Keryx Biopharmaceuticals's Cost of Goods Sold for the three months ended in Sep. 2018 was $8.37 Mil. Hence, Keryx Biopharmaceuticals's Days Inventory for the three months ended in Sep. 2018 was 584.79.

The historical rank and industry rank for Keryx Biopharmaceuticals's Days Inventory or its related term are showing as below:

KERX' s Days Inventory Range Over the Past 10 Years
Min: 238.78   Med: 826.68   Max: 2886.82
Current: 409.69

During the past 13 years, Keryx Biopharmaceuticals's highest Days Inventory was 2886.82. The lowest was 238.78. And the median was 826.68.

KERX's Days Inventory is not ranked
in the Biotechnology industry.
Industry Median: 192.335 vs KERX: 409.69

Keryx Biopharmaceuticals's Days Inventory increased from Sep. 2017 (300.54) to Sep. 2018 (584.79). It might indicate that Keryx Biopharmaceuticals's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Keryx Biopharmaceuticals's Inventory Turnover for the three months ended in Sep. 2018 was 0.16.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Keryx Biopharmaceuticals's Inventory-to-Revenue for the three months ended in Sep. 2018 was 1.91.


Keryx Biopharmaceuticals Days Inventory Historical Data

The historical data trend for Keryx Biopharmaceuticals's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Keryx Biopharmaceuticals Days Inventory Chart

Keryx Biopharmaceuticals Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 5,773.64 1,365.48 244.72 301.67

Keryx Biopharmaceuticals Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 300.54 301.48 284.71 455.58 584.79

Competitive Comparison of Keryx Biopharmaceuticals's Days Inventory

For the Biotechnology subindustry, Keryx Biopharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Keryx Biopharmaceuticals's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Keryx Biopharmaceuticals's Days Inventory distribution charts can be found below:

* The bar in red indicates where Keryx Biopharmaceuticals's Days Inventory falls into.



Keryx Biopharmaceuticals Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Keryx Biopharmaceuticals's Days Inventory for the fiscal year that ended in Dec. 2017 is calculated as

Days Inventory (A: Dec. 2017 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2016 ) + Total Inventories (A: Dec. 2017 )) / count ) / Cost of Goods Sold (A: Dec. 2017 )*Days in Period
=( (12.681 + 28.695) / 2 ) / 25.031*365
=20.688 / 25.031*365
=301.67

Keryx Biopharmaceuticals's Days Inventory for the quarter that ended in Sep. 2018 is calculated as:

Days Inventory (Q: Sep. 2018 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2018 ) + Total Inventories (Q: Sep. 2018 )) / count ) / Cost of Goods Sold (Q: Sep. 2018 )*Days in Period
=( (48.584 + 58.736) / 2 ) / 8.373*365 / 4
=53.66 / 8.373*365 / 4
=584.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Keryx Biopharmaceuticals  (NAS:KERX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Keryx Biopharmaceuticals's Inventory Turnover for the three months ended in Sep. 2018 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Keryx Biopharmaceuticals's Inventory to Revenue for the three months ended in Sep. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Keryx Biopharmaceuticals Days Inventory Related Terms

Thank you for viewing the detailed overview of Keryx Biopharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Keryx Biopharmaceuticals (Keryx Biopharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
Keryx Biopharmaceuticals Inc focuses on developing medicines to people with kidney diseases. The marketed product of the company is auryxia tablet, which is a iron based medicine.
Executives
Scott A Holmes officer: Chief Financial Officer C/O KERYX BIOPHARMACEUTICALS INC 1 MARINA PARK DR., 10TH FLOOR BOSTON MA 02210
Daniel Paul Regan director C/O INTERCEPT PHARMACEUTICALS, INC., 18 DESBROSSES ST., NEW YORK NY 10013
Jodie Pope Morrison director, officer: Interim CEO C/O TOKAI PHARMACEUTICALS, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Mark J Enyedy director C/O FATE THERAPEUTICS, INC., 3535 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO CA 92121
Michael Thomas Heffernan director C/O CORNERSTONE THERAPEUTICS INC., 1255 CRESCENT GREEN DRIVE, SUITE 250, CARY NC 27518
Steven C Gilman director 110 HARTWELL AVENUE, LEXINGTON MA 02421
Michael W Rogers director C/O KERYX BIOPHARMACEUTICALS INC, ONE MARINA PARK DRIVE, BOSTON MA 02210
Baupost Group Gp, L.l.c. 10 percent owner 10 ST. JAMES AVENUE, SUITE 1700, BOSTON MA 02116
Baupost Group Llc/ma director, 10 percent owner 10 ST JAMES AVE, SUITE 1700, BOSTON MA 02116
Seth A Klarman 10 percent owner 10 ST JAMES AVENUE, STE 1700, BOSTON MA 02116
Greg Madison director, officer: President and CEO ONE MARINA PARK DRIVE LEXINGTON MA 02210
Brian Adams officer: General Counsel and Secretary 750 LEXINGTON AVENUE, NEW YORK NY 10022
John P. Butler director C/O RELYPSA, INC., 700 SAGINAW DR., REDWOOD CITY CA 94063
Sak Corp 10 percent owner 10 ST JAMES AVENUE, STE 1700, BOSTON MA 02116
Oliviero James F Iii officer: Chief Financial Officer C/O KERYX BIOPHARMACEUTICALS, INC., 750 LEXINGTON AVENUE, NEW YORK NY 10022

Keryx Biopharmaceuticals (Keryx Biopharmaceuticals) Headlines

From GuruFocus

Keryx Has a Very Good Product, but Is Not Profitable

By Robert Gadimian Robert Gadimian 03-26-2018